InvestorsObserver
×
News Home

Will Intercept Pharmaceuticals Inc (ICPT) Stay at the Top of the Healthcare Sector?

Thursday, August 18, 2022 03:27 PM | InvestorsObserver Analysts

Mentioned in this article

Will Intercept Pharmaceuticals Inc (ICPT) Stay at the Top of the Healthcare Sector?

A rating of 88 puts Intercept Pharmaceuticals Inc (ICPT) near the top of the Healthcare sector according to InvestorsObserver. Intercept Pharmaceuticals Inc's score of 88 means that it ranks higher than 88% of stocks in the sector. In addition, its overall score of 92 ranks it higher than 92% of all stocks.

Overall Score - 92
ICPT has an Overall Score of 92. Find out what this means to you and get the rest of the rankings on ICPT!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Intercept Pharmaceuticals Inc Stock Today?

Intercept Pharmaceuticals Inc (ICPT) stock is trading at $19.45 as of 3:25 PM on Thursday, Aug 18, an increase of $0.73, or 3.87% from the previous closing price of $18.73. The stock has traded between $18.02 and $19.65 so far today. Volume today is above average. So far 1,221,020 shares have traded compared to average volume of 931,228 shares. Click Here to get the full Stock Report for Intercept Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App